Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Price

Showing results (1091-1100 of 1,132) with videos related to

Pageof 114
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 3, 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in AdultsLuis Perez-de-Llano, Ghislaine Scelo, Trung N Tran, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
Frontiers in Immunology|May 7, 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthmaCeleste M Porsbjerg, John Townend, Celine Bergeron, et al.
Translational Psychiatry|May 23, 2026
Brain age prediction in generalized anxiety disorder using a convolutional neural networkCorey Richier, André Zugman, Anita Harrewijn, et al.
Pageof 114

Showing results (1091-1100 of 1,132) with videos related to

Sort By:
Pageof 114
American Journal of Respiratory and Critical Care Medicine|May 3, 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in AdultsLuis Perez-de-Llano, Ghislaine Scelo, Trung N Tran, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
Frontiers in Immunology|May 7, 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthmaCeleste M Porsbjerg, John Townend, Celine Bergeron, et al.
Translational Psychiatry|May 23, 2026
Brain age prediction in generalized anxiety disorder using a convolutional neural networkCorey Richier, André Zugman, Anita Harrewijn, et al.
Pageof 114